H. Lundbeck, The EU commission issues marketing authorisation for Ebixa®

On the basis of a recommendation from the Committee for Proprietary
Medicinal Products (CPMP), the EU commission has now issued a marketing authorisation for Ebixa® covering all EEA countries. Marketing of Ebixa® will commence second half of 2002.